Clinical Efficacy and sAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary Intervention
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1500 participants.
Also called NCT04665648
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,500 participants
- Sponsor
- Registry
-
NCT04665648
-
- Other papers using this trial's data
- Intravenous Nicorandil in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI: The CLEAN Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT04665648. Randomized; quadruple masking; primary purpose treatment. Start 2021-06-01 (actual); primary completion 2024-12-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Efficacy and sAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary Intervention
- Acronym
- CLEAN
- Condition
- ST Elevation Myocardial Infarction
- Condition
- Percutaneous Coronary Intervention
- Intervention (Drug)
- Nicorandil
- Intervention (Drug)
- Placebo
- Lead sponsor
- Fudan University
Record details
- Record id
cardio:ct-nct04665648- Content hash
784bf8e5d1d9559a43292b26fc9373526ac89726fd373f5594ec9b89f300abd9